165 related articles for article (PubMed ID: 36249775)
21. Comparison of DEB-TACE and cTACE for the initial treatment of unresectable hepatocellular carcinoma beyond up-to-seven criteria: A single-center propensity score matching analysis.
Shi Q; Liu J; Li T; Zhou C; Wang Y; Huang S; Yang C; Chen Y; Xiong B
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101893. PubMed ID: 35247625
[TBL] [Abstract][Full Text] [Related]
22. Initial experience of drug-eluting bead transarterial chemoembolization with CalliSpheres
Zhang G; Tang R; Wu J; Jin K; Chao M; Li B
Transl Cancer Res; 2020 Mar; 9(3):1630-1639. PubMed ID: 35117511
[TBL] [Abstract][Full Text] [Related]
23. Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma.
Liu H; Li Y; Li Z; Han X; Ren K
Front Pharmacol; 2023; 14():1170344. PubMed ID: 37284322
[No Abstract] [Full Text] [Related]
24. Drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres for treatment of unresectable intrahepatic cholangiocarcinoma.
Zhou TY; Zhou GH; Zhang YL; Nie CH; Zhu TY; Wang HL; Chen SQ; Wang BQ; Yu ZN; Wu LM; Zheng SS; Sun JH
J Cancer; 2020; 11(15):4534-4541. PubMed ID: 32489470
[No Abstract] [Full Text] [Related]
25. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases.
Zhao G; Liu S; Zhang Y; Zhao T; Wang R; Bian J; Wu J; Zhou J
Ir J Med Sci; 2022 Jun; 191(3):1139-1145. PubMed ID: 34264426
[TBL] [Abstract][Full Text] [Related]
26. Exploring the efficacy and safety of drug-eluting beads transarterial chemoembolization in pancreatic cancer liver metastasis.
Ning Z; Zhu Y; Xie L; Yan X; Hua Y; Meng Z
Br J Radiol; 2024 May; 97(1157):1010-1015. PubMed ID: 38467136
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of vinorelbine loading CalliSpheres beads in the treatment of previously treated advanced lung cancer with progressive refractory obstructive atelectasis.
Ma X; Zheng D; Zhang J; Dong Y; Li L; Jie B; Jiang S
Front Bioeng Biotechnol; 2022; 10():1088274. PubMed ID: 36605253
[No Abstract] [Full Text] [Related]
28. The Efficacy of Drug-eluting Bead Transarterial Chemoembolization Loaded With Oxaliplatin for the Treatment of Stage III-IV Non-small-cell Lung Cancer.
Ren K; Wang J; Li Y; Li Z; Wu K; Zhou Z; Li Y; Han X
Acad Radiol; 2022 Nov; 29(11):1641-1646. PubMed ID: 35177359
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes of uterine arterial chemoembolization with drug-eluting beads for advanced-stage or recurrent cervical cancer.
Bi Y; Wang Y; Zhang J; Shi X; Wang Y; Xu M; Han X; Ren J
Abdom Radiol (NY); 2021 Dec; 46(12):5715-5722. PubMed ID: 34476534
[TBL] [Abstract][Full Text] [Related]
30. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.
Baur J; Ritter CO; Germer CT; Klein I; Kickuth R; Steger U
Hepat Med; 2016; 8():69-74. PubMed ID: 27382341
[TBL] [Abstract][Full Text] [Related]
31. Drug-eluting beads bronchial arterial chemoembolization/bronchial arterial infusion chemotherapy with and without PD-1 blockade for advanced non-small cell lung cancer: a comparative single-center cohort study.
Xu S; Li YM; Bie ZX; Li XG
Quant Imaging Med Surg; 2023 Sep; 13(9):6241-6256. PubMed ID: 37711815
[TBL] [Abstract][Full Text] [Related]
32. Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres
Ma Y; Zhao C; Zhao H; Li H; Chen C; Xiang H; Zheng C; Ma C; Luo C; Qiu H; Yao Y; Hu H; Xiong B; Zhou J; Zhu H; Long Q
Am J Transl Res; 2019; 11(12):7456-7470. PubMed ID: 31934293
[TBL] [Abstract][Full Text] [Related]
33. Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: a pilot study.
Zhao Z; Tu J; Fan X; Song J; Wu F; Ying X; Mao J; Ji J
Transl Cancer Res; 2020 May; 9(5):3191-3202. PubMed ID: 35117685
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.
Chen C; Qiu H; Yao Y; Zhang Z; Ma C; Ma Y; Zhao C; Xiang H; Zhao H; Zheng C; Xiong B; Li H; Long Q; Zhou J; Luo C; Hu H
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101460. PubMed ID: 32593695
[TBL] [Abstract][Full Text] [Related]
35. The Comprehensive Analysis of Efficacy and Safety of CalliSpheres
Peng Z; Cao G; Hou Q; Li L; Ying S; Sun J; Zhou G; Zhou J; Zhang X; Ji W; Yu Z; Li T; Zhu D; Hu W; Ji J; Du H; Shi C; Guo X; Fang J; Han J; Gu W; Xie X; Sun Z; Xu H; Wu X; Hu T; Huang J; Hu H; Zheng J; Luo J; Chen Y; Yu W; Shao G
Oncol Res; 2020 May; 28(3):249-271. PubMed ID: 31856933
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres
Sun J; Zhou G; Xie X; Gu W; Huang J; Zhu D; Hu W; Hou Q; Shi C; Li T; Zhang X; Ji W; Ying S; Peng Z; Zhou J; Yu Z; Ji J; Du H; Guo X; Fang J; Han J; Xu H; Sun Z; Yu W; Shao G; Wu X; Hu H; Li L; Zheng J; Luo J; Chen Y; Cao G; Hu T
Oncol Res; 2020 Feb; 28(1):75-94. PubMed ID: 31558180
[TBL] [Abstract][Full Text] [Related]
37. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.
Luo J; Zheng J; Shi C; Fang J; Peng Z; Huang J; Sun J; Zhou G; Li T; Zhu D; Xu H; Hou Q; Ying S; Sun Z; Du H; Xie X; Cao G; Ji W; Han J; Gu W; Guo X; Shao G; Yu Z; Zhou J; Yu W; Zhang X; Li L; Hu H; Hu T; Wu X; Chen Y; Ji J; Hu W
Medicine (Baltimore); 2020 Mar; 99(12):e19276. PubMed ID: 32195932
[TBL] [Abstract][Full Text] [Related]
38. Super-selective transcatheter vesical arterial chemoembolization with drug-loaded beads for muscle-invasive bladder cancer with hematuria.
Zhou Y; Chen J; Chen P; Tang Y; Wu S; Cai S; Fang Z
Abdom Radiol (NY); 2023 Feb; 48(2):780-786. PubMed ID: 36477632
[TBL] [Abstract][Full Text] [Related]
39. Drug-eluting bead transarterial chemoembolization with medium-sized versus small-sized CalliSpheres microspheres in unresectable primary liver cancer.
Zhang J; Feng GA; Li Y; Wang W
Asia Pac J Clin Oncol; 2022 Aug; 18(4):388-393. PubMed ID: 34708554
[TBL] [Abstract][Full Text] [Related]
40. Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40-75 microns: assessment of efficacy and safety.
Ballı HT; Aikimbaev K
Diagn Interv Radiol; 2020 Sep; 26(5):482-487. PubMed ID: 32815520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
